Company Filing History:

11 out of 1,323

G.d. Searle & Company

patents

1 out of 200

Pharmacia Corporation

patents

1 out of 832,843

Other

patents

Years Active: 1993-2006

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7141599 - [object Object] (2006-11-28),

2. 7132441 - Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor (2006-11-07),

3. 6617345 - Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin (2003-09-09),

4. 6407140 - Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor (2002-06-18),

5. 6376528 - Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor (2002-04-23),

6. 6342510 - Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonist (2002-01-29),

7. 6265439 - Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressives (2001-07-24),

8. 6172096 - Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonist (2001-01-09),

9. 6136839 - Treatment of inflammation and inflammation-related disorders with a (2000-10-24),

10. 5990148 - Treatment of inflammation and inflammation-related disorders with a (1999-11-23),

11. 5700816 - Treatment of inflammation and inflammation-related disorders with a (1997-12-23),

12. 5451604 - Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as (1995-09-19),

13. 5247119 - Phenylacetonitrilehydroxyalkylaminoalkyl-ortho-substituted aryl (1993-09-21),

Title: Innovations and Contributions of Susan A Gregory

Introduction

Susan A Gregory is a prominent inventor based in St. Louis, MO (US). She has made significant contributions to the field of immunology and organ transplantation. With a total of 13 patents, her work has had a profound impact on medical treatments and therapies.

Latest Patents

Among her latest patents, one notable invention involves the treatment with a cyclooxygenase-2 inhibitor and a leukotriene B receptor antagonist. This treatment is described as being useful in reducing recipient rejection of transplanted organs and for the treatment of autoimmune diseases. Another significant patent focuses on the immunosuppressive effects of administering a combination of a cyclooxygenase-2 inhibitor, a 5-lipoxygenase inhibitor, and an immunosuppressive drug. This combination may be utilized to suppress the immune response associated with organ transplantation, graft versus host disease, and conditions with underlying autoimmune or inflammatory reactivities.

Career Highlights

Throughout her career, Susan has worked with notable companies, including G.D. Searle & Company. Her innovative approaches and research have positioned her as a leader in her field.

Collaborations

Susan has collaborated with esteemed colleagues such as Gary D Anderson and Peter C Isakson. These partnerships have further enhanced her research and contributions to medical science.

Conclusion

Susan A Gregory's work exemplifies the spirit of innovation in the medical field. Her patents and collaborations have paved the way for advancements in organ transplantation and autoimmune disease treatment.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com